Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Identification of a new class of potent Cdc7 inhibitors designed by putative pharmacophore model: Synthesis and biological evaluation of 2,3-dihydrothieno[3,2-d]pyrimidin-4(1H)-ones

Journal Article · · Bioorganic and Medicinal Chemistry
Not Available
Sponsoring Organization:
USDOE Office of Science (SC), Basic Energy Sciences (BES)
Grant/Contract Number:
AC02-05CH11231
OSTI ID:
1415314
Journal Information:
Bioorganic and Medicinal Chemistry, Journal Name: Bioorganic and Medicinal Chemistry Journal Issue: 7 Vol. 25; ISSN 0968-0896
Publisher:
ElsevierCopyright Statement
Country of Publication:
United Kingdom
Language:
English

References (20)

Cdc7 kinase complex: A key regulator in the initiation of DNA replication journal February 2002
Synthesis of 7-ethyl-4,7-dihydro-4-oxo-2-(4-pyridinyl)thieno[2,3- b ]pyridine-5-carboxylic acid journal December 1991
Novel Insights into the Roles of Rho Kinase in Cancer journal January 2016
Development of a presynaptic 5-HT1A antagonist journal January 2003
Actin cytoskeleton dynamics and the cell division cycle journal October 2010
The discovery and optimization of pyrimidinone-containing MCH R1 antagonists journal September 2006
Thienopyrimidinone bis-aminopyrrolidine ureas as potent melanin-concentrating hormone receptor-1 (MCH-R1) antagonists journal May 2007
4-(1H-Indazol-5-yl)-6-phenylpyrimidin-2(1H)-one analogs as potent CDC7 inhibitors journal August 2008
Synthesis and evaluation of pyrido-thieno-pyrimidines as potent and selective Cdc7 kinase inhibitors journal January 2009
Aminopyrimidinone Cdc7 Kinase Inhibitors journal March 2012
Discovery of XL413, a potent and selective CDC7 inhibitor journal June 2012
Cdc7 Kinase Inhibitors: 5-Heteroaryl-3-Carboxamido-2-Aryl Pyrroles as Potential Antitumor Agents. 1. Lead Finding journal October 2010
Cdc7 Kinase Inhibitors: Pyrrolopyridinones as Potential Antitumor Agents. 1. Synthesis and Structure–Activity Relationships journal January 2008
First Cdc7 Kinase Inhibitors: Pyrrolopyridinones as Potent and Orally Active Antitumor Agents. 2. Lead Discovery journal January 2009
Crystal structure of human CDC7 kinase in complex with its activator DBF4 journal October 2012
Mammalian Cdc7-Dbf4 protein kinase complex is essential for initiation of DNA replication journal October 1999
A short history of SHELX journal December 2007
Cdc7 Inhibition Reveals a p53-Dependent Replication Checkpoint That Is Defective in Cancer Cells journal October 2004
Lipophilicity in drug discovery journal January 2010
Cdc7-Dbf4 Kinase Overexpression in Multiple Cancers and Tumor Cell Lines Is Correlated with p53 Inactivation journal September 2008

Similar Records

Discovery and optimization of 1,7-disubstituted-2,2-dimethyl-2,3-dihydroquinazolin-4(1H)-ones as potent and selective PKCθ inhibitors
Journal Article · Wed Jun 01 00:00:00 UTC 2016 · Bioorganic and Medicinal Chemistry · OSTI ID:1337404

Discovery of Thieno[3,2-d]pyrimidine-6-carboxamides as Potent Inhibitors of SIRT1, SIRT2, and SIRT3
Journal Article · Tue Aug 26 04:00:00 UTC 2014 · Journal of Medicinal Chemistry · OSTI ID:1084140

Design, synthesis, and antihypertensive activity of new pyrimidine derivatives endowing new pharmacophores
Journal Article · Fri Mar 15 04:00:00 UTC 2019 · Medicinal Chemistry Research (Print) · OSTI ID:22936206

Related Subjects